Skip to main content

Current Heart Failure Reports OnlineFirst articles

25.04.2024 | Review

Economic Considerations of Cardiovascular Implantable Electronic Devices for The Treatment of Heart Failure

Heart failure (HF) is a major public health problem worldwide, affecting more than 64 million people [ 1 ]. The prevalence of HF is increasing due to aging populations, improved survival from cardiovascular diseases, and the growing burden of risk …

verfasst von:
Christian Elsner, Simon Bettin, Roland Tilz, Dennis Häckl

Open Access 18.04.2024 | Review

(Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac Amyloidosis

Cardiac amyloidosis (CA), either triggered by light chain (AL) or transthyretin (TTR) deposition in the heart, results in a restrictive relaxation pattern and heart failure (HF) with reduced prognosis [ 1 ]. Exercise limitations can be directly …

verfasst von:
Simon Wernhart, Lars Michel, Alexander Carpinteiro, Peter Luedike, Tienush Rassaf

15.04.2024 | Review

Putting More Weight on Obesity Trials in Heart Failure

The rising prevalence of obesity is a worldwide public health problem responsible for approximately 4 million deaths and 120 million disability-adjusted life years in 2015 alone [ 1 , 2 ]. Rates of obesity continue to rise in both adults and …

verfasst von:
Josephine Harrington, Naveed Sattar, G Michael Felker, James L. Januzzi, Carolyn S. P. Lam, Neha J. Pagidipati, Ambarish Pandey, Harriette G. C. Van Spall, Darren K. McGuire

09.04.2024 | Review

Combinational Diuretics in Heart Failure

The heart failure (HF) syndrome was described as an emerging epidemic about 25 years ago [ 1 ]. Today, HF remains a serious clinical and public health problem as the total number of patients living with HF is increasing, reflecting the chronic …

verfasst von:
Joan Carles Trullàs, Jesús Casado, Marta Cobo-Marcos, Francesc Formiga, José Luís Morales-Rull, Julio Núñez, Luís Manzano

28.03.2024

Chronic Obstructive Pulmonary Disease in Heart Failure: Challenges in Diagnosis and Treatment for HFpEF and HFrEF

Chronic obstructive pulmonary disease (COPD) is one of the most prevalent comorbidities among patients with HF, especially in HF with preserved ejection fraction (HFpEF) [ 1 ]. Moreover, in patients where HF and COPD coexist, the prevalence of …

verfasst von:
Sergio Henrique Rodolpho Ramalho, André Luiz Pereira de Albuquerque

27.03.2024 | Review

Catheter Ablation of Ventricular Tachycardia in Ischemic Heart Disease: What Is Known and New Perspectives

Cardiovascular diseases are the leading cause of mortality and morbidity in developed countries, accounting for up to 17.8 million deaths globally [ 1 ]. Ischemic heart disease (IHD) plays a major role within the spectrum of cardiovascular diseases …

verfasst von:
Pasquale Valerio Falzone, Sara Vazquez-Calvo, Ivo Roca-Luque

Open Access 21.03.2024 | Review

Is There a Mitochondrial Protection via Remote Ischemic Conditioning in Settings of Anticancer Therapy Cardiotoxicity?

Mitochondria are critical elements for cardiomyocyte function and viability [ 1 , 2 ], and preservation of mitochondrial function is relevant for cellular homeostasis not only in normal but also in transformed malignant cells [ 3 •]. Without any …

verfasst von:
Petra Kleinbongard, Ioanna Andreadou

20.03.2024 | Review

Pregnancy, Reproductive Factors, and Female Heart Failure Risk and Outcomes

Heart failure (HF) affects both men and women. However, studies have shown that women are more likely to develop HF with preserved ejection fraction than men [ 1 ]. This difference may be due, in part, to women-specific factors, such as pregnancy …

verfasst von:
Guillermo Moreno, Manuel Martínez-Sellés, María Jesús Vicente-Galán, Lourdes Vicent

Open Access 15.03.2024 | Review

Non-Coding Ribonucleic Acids as Diagnostic and Therapeutic Targets in Cardiac Fibrosis

Following cardiac insult, fibrosis develops by excessive extracellular matrix (ECM) accumulation that creates tissue microenvironments affected by inflammation and oxidative stress, enhancing profibrotic signaling cascades responsible for tissue …

verfasst von:
Samuel R. Olson, W. H. Wilson Tang, Chia-Feng Liu

15.03.2024 | Review

Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a relatively common inherited cardiac condition, thought to affect 0.2% of the population (1 in 500) [ 1 ••]. The clinical manifestations of HCM range from sudden cardiac death at a young age to incidental …

verfasst von:
Jason N. Dungu, Amy Hardy-Wallace, Anthony D. Dimarco, Henry O. Savage

Open Access 02.03.2024 | Review

Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac Dysfunction

Immune checkpoints are signaling pathways that exert an inhibitory function on the immune system. They lead to an inhibition of T-cell activity by reducing proliferation and triggering apoptosis. The physiological function of immune checkpoints is …

verfasst von:
Lars Michel, Peter Ferdinandy, Tienush Rassaf

27.02.2024 | Review

Evaluation and Management of Hyponatremia in Heart Failure

Hyponatremia, defined as a serum sodium (Na + ) concentration < 135 mmol/L, is the most common electrolyte disorder in hospitalized patients, affecting up to one-third of patients with heart failure (HF), being more frequent in advanced disease [ 1 …–

verfasst von:
Giulio M. Mondellini, Frederik H. Verbrugge

28.11.2019 | Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (A Hasan, Section Editor)

The Approach to the Psychosocial Evaluation of Cardiac Transplant and Mechanical Circulatory Support Candidates

In 2018, the International Society for Heart and Lung Transplantation (ISHLT), in collaboration with the Academy of Psychosomatic Medicine (now the Academy of Consultation-Liaison Psychiatry), the American Society of Transplantation, the …

verfasst von:
Mary Amanda Dew, Andrea F. DiMartini, Fabienne Dobbels, Kathleen L. Grady, Sheila G. Jowsey-Gregoire, Annemarie Kaan, Kay Kendall, Quincy-Robyn Young

19.11.2019 | Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (A Hasan, Section Editor)

Right Ventricular Strain to Assess Early Right Heart Failure in the Left Ventricular Assist Device Candidate

Improvements in mechanical circulatory support have increased the survival and quality of life among patients with advanced heart failure. Continuous-flow left ventricular assist device (LVAD) implantation has recently gained extensive application …

verfasst von:
Fatih Gumus, Cahit Sarıcaoglu, Mustafa Bahadir Inan, Ahmet Ruchan Akar